Myriad Genetics (NASDAQ:MYGN) Cut to Sector Perform at Scotiabank
Scotiabank lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a sector outperform rating to a sector perform rating in a report released on Wednesday, Marketbeat.com reports. The brokerage currently has $6.00 price target on the stock, down from their prior price target of $20.00. A number of other analysts have also commented on […]
Scotiabank lowered shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a sector outperform rating to a sector perform rating in a report released on Wednesday, Marketbeat.com reports. The brokerage currently has $6.00 price target on the stock, down from their prior price target of $20.00. A number of other analysts have also commented on […]
